2007 Media releases

11/21/07	Novartis Pharmaceuticals Canada Inc. wins the 2007 Belleau-Nickerson Award for the cancer drug Gleevec
10/04/07	Novartis Pharmaceuticals Canada Inc. complies with request from Health Canada to withdraw Prexige in Canada
09/19/07	Team of recreational cyclists from Novartis Pharmaceuticals Canada Inc. ride from Toronto to Montreal and raise $90,000 for breast cancer research
09/18/07	First osteoporosis study in patients with hip fracture finds once-yearly Aclasta* prevents additional fractures and improves survival
05/15/07	Novartis Pharmaceuticals Canada Inc. Receives Health Canada Approval for First Fully Automated Nucleic Acid Testing Solution to Screen for West Nile Virus
05/14/07	Sandoz to invest $80 million in Quebec facilities
05/02/07	Once-yearly Aclasta shown to significantly reduce bone fractures in women with postmenopausal osteoporosis
04/30/07	Landmark study shows 40% reduction in cardiovascular events and stroke with Diovan Study halted early due to superior outcomes
04/27/07	Novartis Pharmaceuticals Canada Inc. Lends a Helping Hand on 11th Annual Community Partnership Day
04/13/07	Positive results from cancer study prompt the National Cancer Institute (NCI) to halt study early and offer Gleevec to all trial participants